A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
A deep dive into the scientific shift toward multi-target obesity therapeutics and its implications for metabolic health and disease prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results